At the American Society of Hematology (ASH) 2011, Stephen Hunger, MD, Section Chief, Center for Cancer and Blood Disorders, discusses an overview of ALL, treatment with asparaginase, and the recent US approval of Erwinase® (asparaginase Erwinia chrysanthemi) for the treatment of ALL and the benefits to patients.
Link to this comment:
All Comments (0)